Feld Jordan J, Liang T Jake
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Hepatology. 2006 Feb;43(2 Suppl 1):S194-206. doi: 10.1002/hep.21065.
Hepatitis C follows a variable course with some patients developing progressive liver fibrosis, cirrhosis and hepatocellular carcinoma, while others have minimal or no significant liver disease after decades of infection. Studies have identified both host and viral factors associated with disease progression. The importance of general factors such as age at infection, gender, immune status and alcohol consumption has long been recognized; however recently, polymorphisms in a wide array of genes have also been shown to be associated with progressive fibrosis. How specific viral proteins may contribute to disease progression has also been studied. This review highlights what is currently known about the factors associated with progressive liver injury in patients with hepatitis C. A greater understanding of the determinants of disease progression will hopefully lead to improved utilization of existing treatments and ultimately may aid in identification of new therapeutic targets.
丙型肝炎的病程具有多样性,一些患者会发展为进行性肝纤维化、肝硬化和肝细胞癌,而另一些患者在感染数十年后肝脏疾病轻微或无明显疾病。研究已经确定了与疾病进展相关的宿主和病毒因素。感染时的年龄、性别、免疫状态和饮酒等一般因素的重要性早已得到认可;然而最近,大量基因的多态性也被证明与进行性纤维化有关。特定病毒蛋白如何促进疾病进展也已得到研究。本综述重点介绍了目前已知的与丙型肝炎患者进行性肝损伤相关的因素。对疾病进展决定因素的更深入理解有望提高现有治疗方法的利用率,并最终可能有助于确定新的治疗靶点。